2020
DOI: 10.1016/j.avsg.2019.09.016
|View full text |Cite
|
Sign up to set email alerts
|

Fenestrated Endovascular Repair for Pararenal or Juxtarenal Abdominal Aortic Aneurysms: a Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 44 publications
1
10
0
Order By: Relevance
“…16 Mortality rate at 30-days (1.2%) was low in comparison to reference data, which mostly report 30-day mortality rates around 2.5-3.0%. 1,6 Survival rates at a 1-and 3-year follow-up are in accordance with most of the available literature. 13,[17][18][19] At a 5-year follow-up, survival rates were higher in a reference study, namely 71.0%, than in the current analysis (59.9%).…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…16 Mortality rate at 30-days (1.2%) was low in comparison to reference data, which mostly report 30-day mortality rates around 2.5-3.0%. 1,6 Survival rates at a 1-and 3-year follow-up are in accordance with most of the available literature. 13,[17][18][19] At a 5-year follow-up, survival rates were higher in a reference study, namely 71.0%, than in the current analysis (59.9%).…”
Section: Discussionsupporting
confidence: 88%
“…A recent systematic review on FEVAR in complex AAA reported an estimated 5-year survival of 78%, although this reference meta-analysis did report an inconsistency in followup, as did other literature studies. 1 Deteriorating change in health and physical functioning in the present survey group as compared to the RAND SF-36 baseline data could be attributed to the FEVAR procedure. However, the majority of participants stressed that their decline in physical health was due to other comorbidities (such as COPD).…”
Section: Discussionmentioning
confidence: 60%
See 1 more Smart Citation
“…The patients that initially underwent FEVAR and have the longest follow up were mostly unfit for open repair. Their expected survival may therefore be limited, 15,16 which allows the repair to outlive them, or they may refuse or become too frail to allow a major re-intervention such as F/ BEVAR in FEVAR. This last concept is reinforced by similar findings seen for patients undergoing infrarenal EVAR.…”
Section: Discussionmentioning
confidence: 99%
“…Among them, FEVAR should be considered as a first option 1, due to their reported safety and efficacy in the VQI among others [248][249][250]. In a systematic review of 30 studies including 23,385 pats of whom 2,271 pts were treated with FEVAR for pararenal/juxtarenal AAA, the pooled early mortality reached 2.55% (ranging from 0% to 6.74%), with a pooled technical success of 96.8% (ranging from 82.8% to 100%) [251]. In a multivariate analysis, early mortality was associated with procedure time (HR, 1.007 per minute; P < .001), TAAA preoperative diameter (HR, 1.053 per millimeter; P = .001), and chronic kidney disease (HR, 3.139; P = .007) [252].…”
Section: Large Trials Meta-analyses Databases and Registries On Outcomesmentioning
confidence: 99%